CHEMICAL APPROACHES FOR ACTIVITY BASED PROTEOMICS
基于活性的蛋白质组学的化学方法
基本信息
- 批准号:6633803
- 负责人:
- 金额:$ 29.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The objective of this proposal is to develop and utilize novel
chemical probes for activity-based proteomics investigations aimed at
understanding the role that hydrolytic enzymes play in tumor metastasis. With
the post-genome era rapidly approaching, new strategies for the functional
analysis of proteins are needed. To date, proteomics efforts have primarily
been concerned with recording variations in protein level rather than activity.
The ability to profile classes of proteins based on changes in their activity
would greatly accelerate both the assignment of protein function and the
identification of potential pharmaceutical targets. The work described in this
proposal will focus on designing, synthesizing, and testing novel active
site-directed probes that record dynamics in the expression and function of
entire enzyme families. In this application, the PIs will use synthetic
chemistry, biochemistry, and molecular and cell biology techniques towards the
goals of 1) identifying proteases that support or impede tumor metastasis, 2)
imaging extracellular "hot spots" of proteolytic activity associated with tumor
cell migration and invasion, and 3) developing activity-based probes selective
for the matrix metalloproteinase family of enzymes. Through these studies the
PI hopes to clarify which, of the many, hydrolytic enzymes implicated in cancer
actually participate in proteolytic events important for the progression of the
disease. The enzymes will in turn represent valuable targets for pharmaceutical
efforts aimed at suppressing cancer metastasis.
本提案的目的是开发和利用新颖的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENJAMIN F CRAVATT其他文献
BENJAMIN F CRAVATT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENJAMIN F CRAVATT', 18)}}的其他基金
A platform to identify in vivo targets of covalent cancer drugs in 3D tissues
识别 3D 组织中共价癌症药物体内靶标的平台
- 批准号:
10714543 - 财政年份:2023
- 资助金额:
$ 29.17万 - 项目类别:
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
通过化学蛋白质组学整合配体和靶点发现用于胶质母细胞瘤治疗。
- 批准号:
10652580 - 财政年份:2021
- 资助金额:
$ 29.17万 - 项目类别:
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
通过化学蛋白质组学整合配体和靶点发现用于胶质母细胞瘤治疗。
- 批准号:
10436295 - 财政年份:2021
- 资助金额:
$ 29.17万 - 项目类别:
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
通过化学蛋白质组学整合配体和靶点发现用于胶质母细胞瘤治疗。
- 批准号:
10211553 - 财政年份:2021
- 资助金额:
$ 29.17万 - 项目类别:
RP5: Chemical proteomic discovery of small-molecule probes for autophagy proteins
RP5:自噬蛋白小分子探针的化学蛋白质组学发现
- 批准号:
10364727 - 财政年份:2019
- 资助金额:
$ 29.17万 - 项目类别:
RP5: Chemical proteomic discovery of small-molecule probes for autophagy proteins
RP5:自噬蛋白小分子探针的化学蛋白质组学发现
- 批准号:
10573265 - 财政年份:2019
- 资助金额:
$ 29.17万 - 项目类别:
Chemical Proteomic Platforms for Radically Expanding Cancer Druggability
用于从根本上扩展癌症成药性的化学蛋白质组学平台
- 批准号:
10248401 - 财政年份:2018
- 资助金额:
$ 29.17万 - 项目类别:
Chemical Proteomic Platforms for Radically Expanding Cancer Druggability
用于从根本上扩展癌症成药性的化学蛋白质组学平台
- 批准号:
10477261 - 财政年份:2018
- 资助金额:
$ 29.17万 - 项目类别:
相似海外基金
RUI: Mechanoregulation of Collective Cell Migration in Biomimetic Microenvironments
RUI:仿生微环境中集体细胞迁移的机械调节
- 批准号:
2342274 - 财政年份:2024
- 资助金额:
$ 29.17万 - 项目类别:
Standard Grant
CAREER: Predictive Multiscale Modeling of Cell Migration through Pores between Endothelial Cells
职业:通过内皮细胞之间的孔进行细胞迁移的预测多尺度建模
- 批准号:
2339054 - 财政年份:2024
- 资助金额:
$ 29.17万 - 项目类别:
Standard Grant
Uncovering the Underlying Biophysical Mechanisms of Directed Cell Migration
揭示定向细胞迁移的潜在生物物理机制
- 批准号:
2345411 - 财政年份:2024
- 资助金额:
$ 29.17万 - 项目类别:
Standard Grant
Collaborative Research: DMS/NIGMS 1: Simulating cell migration with a multi-scale 3D model fed by intracellular tension sensing measurements
合作研究:DMS/NIGMS 1:使用由细胞内张力传感测量提供的多尺度 3D 模型模拟细胞迁移
- 批准号:
2347957 - 财政年份:2024
- 资助金额:
$ 29.17万 - 项目类别:
Standard Grant
Collaborative Research: DMS/NIGMS 1: Simulating cell migration with a multi-scale 3D model fed by intracellular tension sensing measurements
合作研究:DMS/NIGMS 1:使用由细胞内张力传感测量提供的多尺度 3D 模型模拟细胞迁移
- 批准号:
2347956 - 财政年份:2024
- 资助金额:
$ 29.17万 - 项目类别:
Standard Grant
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
- 批准号:
10520211 - 财政年份:2023
- 资助金额:
$ 29.17万 - 项目类别:
Actin gating of crosstalk between Rho GTPases in cell migration
细胞迁移中 Rho GTP 酶之间串扰的肌动蛋白门控
- 批准号:
10736927 - 财政年份:2023
- 资助金额:
$ 29.17万 - 项目类别:
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
完整项目 1:MICAL 依赖性胰腺癌细胞迁移的定义机制
- 批准号:
10762273 - 财政年份:2023
- 资助金额:
$ 29.17万 - 项目类别:
Localized mitochondrial metabolic activity in Xenopus mesendoderm cells undergoing collective cell migration
爪蟾中内胚层细胞集体细胞迁移的局部线粒体代谢活性
- 批准号:
10751722 - 财政年份:2023
- 资助金额:
$ 29.17万 - 项目类别:
Mechanisms underlying a decline in neural stem cell migration during aging
衰老过程中神经干细胞迁移下降的机制
- 批准号:
10750482 - 财政年份:2023
- 资助金额:
$ 29.17万 - 项目类别: